Scipher Medicine and Leading Medical Researchers in Network and Data Science Compress Time to Identify COVID-19 Treatments From Years to Months
June 08, 2021 08:00 ET
|
Scipher Medicine Corporation
Study demonstrates Scipher Medicine’s ability to analyze patient data to identify novel treatments.Scipher will focus on pharma collaborations in autoimmune diseases. WALTHAM, Mass., June 08, 2021 ...
LaunchWorks and Canadienzyme Collaboration Results in New Product for Diagnostic Testing
May 26, 2021 09:00 ET
|
LaunchWorks LLC
ANJOU, Quebec, May 26, 2021 (GLOBE NEWSWIRE) -- LaunchWorks, a contract development and manufacturing organization (CDMO) in molecular diagnostics, and Canadienzyme, a biotech spin-off company by...
LaunchWorks Scales up its Diagnostic Test Kit Manufacturing Capabilities
May 06, 2021 10:00 ET
|
LaunchWorks LLC
BEVERLY, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- LaunchWorks, a contract and development organization serving the diagnostics industry, today announced that it has increased its filling capacity for...
LaunchWorks Opens New Facility in Anjou Canada
May 04, 2021 09:55 ET
|
LaunchWorks LLC
ANJOU, Quebec, May 04, 2021 (GLOBE NEWSWIRE) -- LaunchWorks, a contract development and manufacturing organization (CDMO) serving the diagnostics industry, today announced the opening of a new...
Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting
April 08, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing...
Point of Care Molecular Diagnostics Market to be Worth $2.32 billion by 2027- Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®
April 01, 2021 07:30 ET
|
Meticulous Market Research Pvt. Ltd.
London, April 01, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “Point of Care Molecular Diagnostics Market by Product & Service (Assay, Analyzer, Software, Service),...
Progenity Provides Corporate Updates and Reports Fourth Quarter and Full-Year 2020 Financial Results
March 18, 2021 16:05 ET
|
Progenity, Inc.
Reports approximately 82,000 tests in the fourth quarter of 2020 Raised $118M gross proceeds in December 2020 from a concurrent secondary equity offering and issuance of convertible notes, and $25M...
Progenity to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
March 12, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity Announces $25 Million Private Placement
February 23, 2021 07:45 ET
|
Progenity, Inc.
SAN DIEGO, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing...
Progenity Initiates Safety and Tolerability Study of its Smart Capsule-Based Oral Drug Delivery System for GI Diseases
February 17, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing...